Research and Markets, the largest resource for market research information in world providing essential market research reports, industry research, industry analysis, forecasts, market studies, company profiles and country reports.
Welcome - Register - Login - Help/FAQ - 0 items View Basket
Worlds Largest Market Research Resource - 1516232 Live Reports
Search Research and Markets
  Search
Enter keywords, a title or
a report id number below.





Advanced   
Company search
Register for free email updates of market research
Currency
  Select a currency for use throughout the site



Viewing report

Order by Fax
Ask a Question
Printer Friendly
PDF Brochure
Site LicenseAdd to Basket
EnterprisewideAdd to Basket
Electronic (PDF)Add to Basket
Live Chat Live Help Software for Website

AtriCure, Inc. (ATRC) - Financial and Strategic SWOT Analysis Review

GlobalData, April 2012, Pages: 44


  Description  
   Table of Contents   
   Companies Mentioned   
    
    
     
  Enquire before Buying   
  Send to a Friend   

AtriCure, Inc. (ATRC) - Financial and Strategic SWOT Analysis Review

Summary

AtriCure, Inc. (AtriCure) is a medical device company principally engaged in the development, manufacturing and selling of innovative cardiac surgical ablation devices. The company's ablation devices are designed to create precise lesions or scars in cardiac and soft tissues. Cardiothoracic surgeons use its proprietary bipolar ablation technology to create lesions in cardiac tissue to block the abnormal electrical impulses that result in atrial fibrillation. AtriCure also provides a multifunctional bipolar pen that is used in combination with its Isolator system in order to ablate cardiac tissue and for sensing, temporary pacing, stimulating and recording during the evaluation of cardiac arrhythmias. The company is headquartered in Ohio, the US.


The company's strategy is to offer innovative and technically superior products. It seeks to obtain expanded US Food and Drug Administration (FDA) clearances and approvals in order to achieve market acceptance for its products and further develop products. Recently the company's Synergy Ablation System for the treatment of atrial fibrillation (AF) received the US FDA.

AtriCure, Inc. Key Recent Developments

Feb 27, 2012: AtriCure Reports Revenue Of $64.4m In 2011
Nov 17, 2011: AtriCure Updates On DEEP AF Feasibility Trial
Nov 01, 2011: AtriCure Reports Revenues Of $15.2m In Q3 2011
Aug 02, 2011: AtriCure Reports Revenue Of $16.8m In Q2 2011
Jul 15, 2011: AtriCure Receives $1m For Minimally Invasive Left Appendage Exclusion System

This comprehensive SWOT profile of AtriCure, Inc. provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.



Customers who bought this item also bought

AtriCure, Inc. Market Share Analysis

AtriCure, Inc. (ATRC) - Product Pipeline Analysis

Hansen Medical, Inc. (HNSN) - Product Pipeline Analysis

Biosense Webster, Inc.Market Share Analysis

Cardima, Inc. (CADM) - Product Pipeline Analysis

St. Jude Medical, Inc. (STJ) - Financial and Strategic SWOT Analysis Review

Syneron Medical Ltd. (ELOS) - Financial and Strategic SWOT Analysis Review

GlaxoSmithKline plc (GSK) - Financial and Strategic SWOT Analysis Review

Nordion Inc. (NDN) - Financial and Strategic SWOT Analysis Review

ResMed Inc. (RMD) - Financial and Strategic SWOT Analysis Review



For enquiries please call us on:
  +353-1-415-1241 (GMT Office Hours)
  1-800-526-8630 (US/Canada Toll Free)
  1-917-300-0470 (EST Office Hours)

   All rights reserved. © Copyright 2012 Research and Markets
   Terms and conditions Privacy Policy Publishers Employment Opportunities Site Map Link to us Webmaster Affiliate Network


Research and Markets RSS Feeds